XML 24 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Treasury Shares
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022   45,928,000        
Balance at beginning of period at Dec. 31, 2022 $ 775,010 $ 46   $ 924,095 $ (148,751) $ (380)
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options (in shares)   63,000        
Exercise of stock options 1,939     1,939    
Vested restricted stock units (in shares)   386,000        
Common stock issued under employee stock purchase plan (in shares)   50,000        
Common stock issued under employee stock purchase plan 1,672     1,672    
Stock-based compensation 35,475     35,475    
Other comprehensive income (Note 10) 370         370
Net (loss) income 17,085       17,085  
Ending balance (in shares) at Sep. 30, 2023   46,427,000        
Balance at ending of period at Sep. 30, 2023 831,551 $ 46   963,181 (131,666) (10)
Beginning balance (in shares) at Jun. 30, 2023   46,409,000        
Balance at beginning of period at Jun. 30, 2023 807,975 $ 46   950,626 (142,524) (173)
Increase (Decrease) in Stockholders' Equity            
Exercise of stock options (in shares)   1,000        
Exercise of stock options 25     25    
Vested restricted stock units (in shares)   17,000        
Stock-based compensation 12,530     12,530    
Other comprehensive income (Note 10) 163         163
Net (loss) income 10,858       10,858  
Ending balance (in shares) at Sep. 30, 2023   46,427,000        
Balance at ending of period at Sep. 30, 2023 $ 831,551 $ 46   963,181 (131,666) (10)
Beginning balance (in shares) at Dec. 31, 2023 46,481,174 46,481,000        
Treasury Shares, Beginning balance (in shares) at Sep. 30, 2024 (837,240)   (837,000)      
Balance at beginning of period at Dec. 31, 2023 $ 870,130 $ 46 $ 0 976,633 (106,796) 247
Increase (Decrease) in Stockholders' Equity            
Vested restricted stock units (in shares)   448,000        
Vested restricted stock units 1 $ 1        
Common stock withheld for employee withholding tax liabilities on vested restricted stock units $ (414)     (414)    
Common stock issued under employee stock purchase plan (in shares) 56,077 56,000        
Common stock issued under employee stock purchase plan $ 1,364     1,364    
Stock-based compensation 38,905     38,905    
Purchase of treasury stock, inclusive of excise taxes (in shares)     (837,000)      
Purchase of treasury stock, inclusive of excise tax (25,121)   $ (25,121)      
Purchase of capped call transaction, net of tax (20,112)     (20,112)    
Other comprehensive income (Note 10) 431         431
Net (loss) income $ (115,601)       (115,601)  
Ending balance (in shares) at Sep. 30, 2024 46,148,146 46,985,000        
Treasury Shares, Ending balance (in shares) at Dec. 31, 2023 0   0      
Balance at ending of period at Sep. 30, 2024 $ 749,583 $ 47 $ (25,121) 996,376 (222,397) 678
Beginning balance (in shares) at Jun. 30, 2024   46,954,000        
Treasury Shares, Beginning balance (in shares) at Sep. 30, 2024 (837,240)   (837,000)      
Balance at beginning of period at Jun. 30, 2024 $ 879,278 $ 47 $ (25,121) 983,178 (78,931) 105
Increase (Decrease) in Stockholders' Equity            
Vested restricted stock units (in shares)   31,000        
Common stock withheld for employee withholding tax liabilities on vested restricted stock units (32)     (32)    
Stock-based compensation 13,230     13,230    
Other comprehensive income (Note 10) 573         573
Net (loss) income $ (143,466)       (143,466)  
Ending balance (in shares) at Sep. 30, 2024 46,148,146 46,985,000        
Treasury Shares, Ending balance (in shares) at Jun. 30, 2024     (837,000)      
Balance at ending of period at Sep. 30, 2024 $ 749,583 $ 47 $ (25,121) $ 996,376 $ (222,397) $ 678